Data / Form D filings / ONCOSYNERGY, INC.
ONCOSYNERGY, INC.: Form D filings
ONCOSYNERGY, INC., a biotechnology company in Stamford, CT, filed 7 Form D notices with the SEC between 2018 and 2026. The latest, on May 26, 2026, reports $6.6 million sold of a $8.2 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2 RAVENGLASS DR., Stamford, CT, 06903
- Phone
- (415) 299-4249
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1556747
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | New notice | $8,208,830 | $6,608,832 | $1,599,998 | 5 | May 11, 2026 | sec.gov |
| May 16, 2022 | Amendment | $7,250,000 | $3,452,500 | $3,797,500 | 4 | Nov 12, 2020 | sec.gov |
| Aug 30, 2021 | Amendment | $3,250,000 | $2,452,500 | $797,500 | 4 | Nov 12, 2020 | sec.gov |
| Nov 24, 2020 | New notice | $2,000,000 | $250,000 | $1,750,000 | 1 | Nov 12, 2020 | sec.gov |
| Sep 8, 2020 | Amendment | $5,000,000 | $3,250,000 | $1,750,000 | 6 | May 20, 2019 | sec.gov |
| May 24, 2019 | New notice | $5,000,000 | $200,000 | $4,800,000 | 2 | May 20, 2019 | sec.gov |
| May 14, 2018 | New notice | $21,006,575 | $20,006,575 | $1,000,000 | 23 | Apr 30, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Allen Salmasi | Director | |
| Hen Suh Park | Director | |
| Anne-Marie Carbonell | Executive Officer, Director |
Other biotechnology companies in Connecticut that filed recently
- Allyx Therapeutics, Inc. $27.9 million · Oct 21, 2026
- Cloverleaf Bio, Inc. $14.8 million · Sep 9, 2026
Every Form D from the week of May 25, 2026 · All recent filings in Connecticut · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ONCOSYNERGY, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.